Showing results (2131-2140 of 2,189) with videos related to

Sort By:
Pageof 219
Plos One|September 28, 2011
Genetics of sputum gene expression in chronic obstructive pulmonary diseaseWeiliang Qiu, Michael H Cho, John H Riley, et al.
Annals of Internal Medicine|October 1, 1994
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trialD W Maher, G J Lieschke, M Green, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory functionEmma S Winkler, Adam L Bailey, Natasha M Kafai, et al.
The Journal of Infectious Diseases|March 16, 2011
Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki diseaseAnne H Rowley, Susan C Baker, Stanford T Shulman, et al.
Cell Host & Microbe|February 21, 2020
An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and PathogenesisArthur S Kim, Ofer Zimmerman, Julie M Fox, et al.
Cell|December 10, 2020
Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus InfectionLauren E Williamson, Theron Gilliland, Pramod K Yadav, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 16, 2017
Specificities of Ischemic Stroke Risk Factors in Arab-Speaking CountriesHalim Abboud, Leila Sissani, Julien Labreuche, et al.
Scientific Reports|June 15, 2024
Disruption in glutathione metabolism and altered energy production in the liver and kidney after ischemic acute kidney injury in micePeter R Baker, Amy S Li, Benjamin R Griffin, et al.
ACS Medicinal Chemistry Letters|August 16, 2019
Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4)Carl A Brooks, Linda S Barton, David J Behm, et al.
Science Translational Medicine|August 20, 2025
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.
Pageof 219